Journals / Turkish journal of nephrology (Online) / 2019 / Cilt: 28 - Sayı: 1

Evaluation of Genotypic and Phenotypic Characteristics of Children with Familial Mediterranean Fever in Eastern Turkey

Pages
68–74
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The most common homozygous mutation wasM694V (57.7%), the most common heterozygous mutation was E148Q (38.4%), and the most common compound heterozygous mutation was M694V/M680I (17.1%).Conclusion: In our study, we found that the frequency of mutations was similar to that of the whole population of Turkey,and the severity of the disease was lower.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Familial Mediterranean fever (FMF) is a hereditary disease.
📊
Key Findings & Data:This retrospective study was conducted to evaluate phenotype-genotype characteristics ofchildren with FMF in Malatya district and surrounding areas in eastern Turkey.Materials and methods: A total of 427 patients who had been diagnosed with clinical FMF between 2006 and 2015 wereincluded in the study.Results: Of the patients, 207 (48.5%) were female, and 220 (51.5%) were male.
💡
Conclusion & Impact:The most common homozygous mutation wasM694V (57.7%), the most common heterozygous mutation was E148Q (38.4%), and the most common compound heterozygous mutation was M694V/M680I (17.1%).Conclusion: In our study, we found that the frequency of mutations was similar to that of the whole population of Turkey,and the severity of the disease was lower.
🔬Design:Research Article
📍Scope:2006 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: Familial Mediterranean fever (FMF) is a hereditary disease. It usually affects countries in the Mediterraneanregion and is common in Turks. This retrospective study was conducted to evaluate phenotype-genotype characteristics ofchildren with FMF in Malatya district and surrounding areas in eastern Turkey.Materials and methods: A total of 427 patients who had been diagnosed with clinical FMF between 2006 and 2015 wereincluded in the study.Results: Of the patients, 207 (48.5%) were female, and 220 (51.5%) were male. The mean age of diagnosis was 7.7±3.7years, and the age of onset of complaints was 5.7±3.5 years. The delay of diagnosis was 1.9±1.8 years. The most commoncomplaint was abdominal pain (95.1%). The most commonly detected mutant allele was M694V (26.9%) mutation. Wedetected heterozygous mutations in 203 (52%) patients, homozygous mutations in 71 (18%) patients, compound heterozygous mutations in 81 (22%) patients, and no mutation in 8% of the patients. The most common homozygous mutation wasM694V (57.7%), the most common heterozygous mutation was E148Q (38.4%), and the most common compound heterozygous mutation was M694V/M680I (17.1%).Conclusion: In our study, we found that the frequency of mutations was similar to that of the whole population of Turkey,and the severity of the disease was lower.

🔖

Cite This Article

KALEM, H., TETİK, B. K., TABEL, Y., SELÇUK, E. B., ELMAS, A. T. (2019). Evaluation of Genotypic and Phenotypic Characteristics of Children with Familial Mediterranean Fever in Eastern Turkey. Turkish journal of nephrology (Online), Cilt: 28 - Sayı: 1, 68–74. https://ajindex.com/articles/374951

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Ben-Chetrit E. Familial mediterranean fever (FMF) and renal AA amyloidosis phenotype genotype correlation, treatment and prognosis. J Nephrol 2003; 16: 431-4
  2. Drenth JP, Van der Meer JW. Hereditary periodic fever. N Engl J Med 2001; 345: 1748-57. [CrossRef] 3. Yilmaz E, Dinçel N, Sözeri B, Ozdemir K, Bulut IK, Berdeli A, et al. Familial Mediterranean fever in children from the Aegean region of Turkey: gene mutation frequencies and phenotype-genotype correlation. Turk J Med Sci 2015; 45: 1198-206. [CrossRef] 4. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The international FMF Consortium. Cell 1997; 90: 797-807. [CrossRef] 5. The French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997; 17: 25-31. [CrossRef] 6. Chae JJ, Aksentijevich I, Kastner Daniel L. Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. Br J Haematol 2008; 146: 467-78. [CrossRef] 7. Ben Chetrit E, Touitou I. Familial Mediterranean Fever in the World. Arthritis Rheum 2009; 61: 1447-53. [CrossRef] 8. Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet 1998; 351: 659-64. [CrossRef] 9. Samuels J, Aksentijevich I, Torosyan Y, Centola M, Deng Z, Sood R, et al. Familial Mediterranean fever at the Millennium Clinical spectrum ancient mutations and a survey of 100 American referrals to the National institutes of Health. Medicine (Baltimore) 1998; 77: 268-97. [CrossRef] 10. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever: A survey of 470 cases and review of the literature. Am J Med 1967; 43: 227-53. [CrossRef] 11. Yalçinkaya F, Ozen S, Ozçakar ZB, Aktay N, Cakar N, Düzova A, et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology (Oxford) 2009; 48: 395-8. [CrossRef] 12. Pras E, Livneh A, Balow JE Jr, Pras E, Kastner DL, Pras M. Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 1998; 75: 216-9. [CrossRef] 13. Yesilada E, Taskapan H, Gulbay G. Prevalence of known mutations and a novel missense mutation (M694K) in the MEFV gene in a population from the Eastern Anatolia Region of Turkey. Gene 2012; 511: 371-4. [CrossRef] 14. Goldfinger SE. Colchicine for familial Mediterranean fever. N Eng J Med 1972; 287: 1302. [CrossRef] 15. Siegal S. Benign paroxysmal peritonitis. Gastroenterology 1949; 12: 234-47
  3. Localiza